Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if an investigational drug, called RT001 Botulinum
Toxin Type A Topical Gel, is safe and useful in minimizing the wrinkles between the eye and
hairline called crow's feet, also known as lateral canthal lines.
Phase:
Phase 2
Details
Lead Sponsor:
Revance Therapeutics, Inc.
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA